We constructed a three-gene prognostic signature consisting of TXNRD1, GLA and GSTZ1 which was associated with overall survival for ovarian cancer patients received platinum-based chemotherapy, especially in those with elder age, high pathological grade and advanced tumor stage. The gene discussed is TXNRD1; the disease is neoplasm.